当前位置:首页 - 行情中心 - 天域生物(603717) - 财务分析 - 利润表

天域生物

(603717)

  

流通市值:21.35亿  总市值:21.35亿
流通股本:2.90亿   总股本:2.90亿

利润表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、营业总收入225,272,371.07801,506,706.66624,472,530.5423,381,788.06
营业收入225,272,371.07801,506,706.66624,472,530.5423,381,788.06
二、营业总成本226,794,913.72848,060,136.01594,720,864.52414,460,678.23
营业成本190,100,655.77714,680,430.17501,189,408.91360,172,864.67
税金及附加381,745.062,130,173.781,219,476.68857,083.44
销售费用910,389.174,541,607.342,854,511.232,001,667.61
管理费用17,447,820.1105,129,417.0773,712,418.8749,757,802.04
研发费用4,320,459.4111,611,258.646,607,811.493,459,770.68
财务费用13,633,844.219,967,249.019,137,237.34-1,788,510.21
其中:利息费用12,132,363.8436,528,507.7225,342,543.2523,525,135.05
其中:利息收入381,966.6929,681,457.6519,044,788.925,793,452.09
加:公允价值变动收益--428,240-82,458.54177,760
加:投资收益24,904.75214,519.02487,708.97383,003.51
资产处置收益24,100,263.3-665,551.31-469,532.31-656,694.11
资产减值损失(新)-42,055.87-15,837,153.917,322,808.988,682,139.53
信用减值损失(新)4,227,519.86-27,361,848.82-12,106,516.72-7,165,855.02
其他收益97,225.14960,779.18683,392.04529,174.5
营业利润平衡项目0000
四、营业利润26,885,314.53-89,670,925.1925,587,068.410,870,638.24
加:营业外收入765,285.47,960,815.077,370,164.147,151,905.73
减:营业外支出379,850.615,448,273.345,771,417.833,277,811.89
利润总额平衡项目0000
五、利润总额27,270,749.32-87,158,383.4627,185,814.7114,744,732.08
减:所得税费用174,772.76-315,270.97-95,316.91,043,528.27
六、净利润27,095,976.56-86,843,112.4927,281,131.6113,701,203.81
持续经营净利润27,095,976.56-86,843,112.4927,281,131.6113,701,203.81
归属于母公司股东的净利润13,768,228.59-107,357,787.626,387,662.076,228,578.44
少数股东损益13,327,747.9720,514,675.1320,893,469.547,472,625.37
(一)基本每股收益0.05-0.370.020.02
(二)稀释每股收益0.05-0.370.020.02
九、综合收益总额27,095,976.56-86,843,112.4927,281,131.6113,701,203.81
归属于母公司股东的综合收益总额13,768,228.59-107,357,787.626,387,662.076,228,578.44
归属于少数股东的综合收益总额13,327,747.9720,514,675.1320,893,469.547,472,625.37
公告日期2025-04-302025-04-162024-10-312024-08-31
审计意见(境内)标准无保留意见
TOP↑